Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cormedix Inc (CRMD)

Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Best Momentum Stocks to Buy for November 8th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 8:CorMedix Inc. CRMD: This biopharmaceutical company has a Zacks Rank #1 and witnessed...

SPPJY : 2.8280 (+1.00%)
CRMD : 10.76 (+0.19%)
FFIC : 17.25 (+1.05%)
New Strong Buy Stocks for November 8th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Sappi Limited SPPJY: This wood fiber-based renewable resources company has seen the Zacks Consensus Estimate for its current year...

NTGR : 24.10 (-0.29%)
SPPJY : 2.8280 (+1.00%)
AACAY : 3.9800 (+4.79%)
CRMD : 10.76 (+0.19%)
FFIC : 17.25 (+1.05%)
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

CRMD : 10.76 (+0.19%)
CorMedix (CRMD) Q3 2024 Earnings Call Transcript

CRMD earnings call for the period ending September 30, 2024.

CRMD : 10.76 (+0.19%)
CorMedix: Q3 Earnings Snapshot

CorMedix: Q3 Earnings Snapshot

CRMD : 10.76 (+0.19%)
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

CRMD : 10.76 (+0.19%)
CorMedix Inc. Announces New Data at ASN Kidney Week 2024

CRMD : 10.76 (+0.19%)
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

CRMD : 10.76 (+0.19%)
CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator

CRMD : 10.76 (+0.19%)
CorMedix (CRMD) Q2 2024 Earnings Call Transcript

CRMD earnings call for the period ending June 30, 2024.

CRMD : 10.76 (+0.19%)

Barchart Exclusives

Is Palo Alto Networks Stock a Buy or Sell?
Palo Alto delivered better-than-expected revenue and profitability in Q1, and the cybersecurity giant even raised its full-year guidance. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar